Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD4 | P21917 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5143932 | 1.00 | DRD4 (0.47) | DRD4ALDH1A1MAPK1TDP1CRBN | |
| SCHEMBL1402675 | 0.89 | DRD4 (0.36) | DRD4ALDH1A1TDP1CRBNCHRM2 | |
| SCHEMBL1402646 | 0.85 | ALDH1A1 (0.41) | DRD4ALDH1A1TDP1CRBNCHRM2 | |
| SCHEMBL10187441 | 0.84 | TDP1 (0.47) | DRD4ALDH1A1TDP1TSHRMAOA | |
| SCHEMBL15700020 | 0.83 | CHRM2 (0.40) | DRD4ALDH1A1MAPK1TDP1CRBN | |
| SCHEMBL1402587 | 0.83 | DRD4 (0.34) | DRD4ALDH1A1TDP1CRBNCHRM2 | |
| SCHEMBL83271 | 0.83 | CHRM2 (0.40) | DRD4ALDH1A1MAPK1TDP1CRBN | |
| SCHEMBL1402349 | 0.80 | TDP1 (0.41) | DRD4ALDH1A1TDP1CRBNCHRM2 | |
| SCHEMBL25292616 | 0.79 | ALDH1A1 (0.33) | DRD4ALDH1A1TDP1TSHRSMN1; SMN2 | |
| SCHEMBL10533009 | 0.79 | CRBN (0.45) | ALDH1A1CRBNMAOAMAOBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0605937-B1 | Antistatic resin composition | DAISO CO LTD (JP) | 1997-06-11 | — | — | EP | claimed |
| EP-0605937-A1 | Antistatic resin composition | DAISO CO., LTD. (JP) | 1994-07-13 | — | — | EP | claimed |
| US-4246189-A | FOR EASE OF MATERIALS HANDLING | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1981-01-20 | — | — | US | claimed |
| CN-115989217-A | Composition, and optical material and lens using the same | 三菱瓦斯化学株式会社 | 2023-04-18 | — | — | CN | disclosed |
| US-20210130316-A1 | MORPHINAN DERIVATIVES AND COMPOSITIONS COMPRISING THE SAME FOR TREATING AUTOIMMUNE, INFLAMMATION OR INFECTION RELATED DISORDERS | TAIWANJ PHARMACEUTICALS CO., LTD (TW) | 2021-05-06 | — | — | US | disclosed |
| EP-3565556-A1 | MORPHINAN DERIVATIVES AND COMPOSITIONS COMPRISING THE SAME FOR TREATING AUTOIMMUNE, INFLAMMATION OR INFECTION RELATED DISORDERS | Taiwanj Pharmaceuticals Co., Ltd. (TW) | 2019-11-13 | — | — | EP | disclosed |
| WO-2018128798-A1 | MORPHINAN DERIVATIVES AND COMPOSITIONS COMPRISING THE SAME FOR TREATING AUTOIMMUNE, INFLAMMATION OR INFECTION RELATED DISORDERS | TAIWANJ PHARMACEUTICALS CO., LTD (TW) | 2018-07-12 | — | — | WO | disclosed |
| CN-101910275-B | Additive for polymerizable composition, polymerizable composition containing the same, and use of the polymerizable composition | MITSUI CHEMICALS INC | 2013-06-05 | — | — | CN | disclosed |
| CN-101910275-A | Additive for polymerizable composition, polymerizable composition containing the same, and use of the polymerizable composition | MITSUI CHEMICALS INC | 2010-12-08 | — | — | CN | disclosed |
| US-20070249702-A1 | CALCILYTIC COMPOUNDS | GLAXOSMITHKLINE LLC | 2007-10-25 | — | — | US | disclosed |
| US-7202261-B2 | Calcilytic compounds | NPS PHARMACEUTICALS, INC. (US) | 2007-04-10 | — | — | US | disclosed |
| US-5010198-A | Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents | JANSSEN PHARMACEUTICA N.V. (BE) | 1991-04-23 | — | — | US | disclosed |
| EP-0184257-B1 | BENZOXAZOL- AND BENZOTHIAZOLAMINE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1990-07-25 | — | — | EP | disclosed |
| EP-0354871-A2 | Corrosion inhibition | CIBA-GEIGY AG (CH) | 1990-02-14 | — | — | EP | disclosed |
| US-4861785-A | Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents | JANSSEN PHARMACEUTICA N.V. (BE) | 1989-08-29 | — | — | US | disclosed |
| EP-0184257-A1 | Benzoxazol- and benzothiazolamine derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1986-06-11 | — | — | EP | disclosed |
| US-4567264-A | ADRENERGIC BLOCKING AGENTS | SYNTEX (U.S.A.) INC. (US) | 1986-01-28 | — | — | US | disclosed |
| EP-0126449-A1 | Cardioselective aryloxy- and arylthio-hydroxypropyl piperazinyl acetanilides wich affect calcium entry | SYNTEX (U.S.A.) INC. (US) | 1984-11-28 | — | — | EP | disclosed |
| US-4246189-A | FOR EASE OF MATERIALS HANDLING | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1981-01-20 | — | — | US | disclosed |
| US-4059588-A | RING CLOSURE | ICI AUSTRALIA LIMITED (AU) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130316-A1 | MORPHINAN DERIVATIVES AND COMPOSITIONS COMPRISING THE SAME FOR TREATING AUTOIMMUNE, INFLAMMATION OR INFECTION RELATED DISORDERS | TLR4, TLR1, TLR3 | DRD4 483/4885ALDH1A1 4594/4885MAPK1 359/4885 |
| US-20070249702-A1 | CALCILYTIC COMPOUNDS | CALCR, CASR, ORAI1 | DRD4 3589/4885ALDH1A1 4327/4885MAPK1 3122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.